Series E funding round for RedShift BioAnalytics raising $20M in October 2021
Series E funding round for RedShift BioAnalytics raising $20M in October 2021
| Investor | Firm Type | Partner |
|---|
| Corporate Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$52M
Top Valuation
-
RedShift BioAnalytics raised $20M in a Series E round.
The round was announced on 10/01/21.
The round was led by Illumina Ventures.